We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
-14.02%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$8.88B
AUM Growth
-$1.57B
Cap. Flow
+$103M
Cap. Flow %
1.15%
Top 10 Hldgs %
15.32%
Holding
763
New
20
Increased
297
Reduced
294
Closed
39

Top Buys

Rank Stock Value
1
UL icon
Unilever
UL
+$28M
2
PRGO icon
Perrigo
PRGO
+$25.4M
3
J icon
Jacobs Solutions
J
+$23.4M
4
ICUI icon
ICU Medical
ICUI
+$21.3M
5
SSB icon
SouthState Bank Corp
SSB
+$20.1M

Sector Composition

Rank Sector Weight
1 Technology 19.41%
2 Healthcare 18.06%
3 Industrials 15.07%
4 Financials 12.92%
5 Consumer Discretionary 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNP icon
126
Union Pacific
UNP
$174B
$19.9M 0.22%
93,134
-513
-0.5% -$117K
INVX
127
Innovex International
INVX
$1.8B
$19.8M 0.22%
765,682
+4,987
+0.7% +$152K
CSL icon
128
Carlisle Companies
CSL
$13.5B
$19.7M 0.22%
82,649
+2,150
+3% +$535K
NTRS icon
129
Northern Trust
NTRS
$21.8B
$19.3M 0.22%
200,032
-1,133
-0.6% -$120K
BCRX icon
130
BioCryst Pharmaceuticals
BCRX
$2.42B
$19.3M 0.22%
1,823,209
+879,417
+93% +$9.07M
AVGO icon
131
Broadcom
AVGO
$1.76T
$19.2M 0.22%
394,670
-11,150
-3% -$626K
WSBC icon
132
WesBanco
WSBC
$4.02B
$19M 0.21%
598,305
+4,927
+0.8% +$162K
EFSC icon
133
Enterprise Financial Services Corp
EFSC
$2.4B
$17.5M 0.2%
422,054
+6,989
+2% +$311K
AVA icon
134
Avista
AVA
$3.43B
$17.4M 0.2%
400,274
+1,997
+0.5% +$85.9K
SUM
135
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$17.2M 0.19%
752,835
+3,782
+0.5% +$100K
DRI icon
136
Darden Restaurants
DRI
$24.3B
$17.2M 0.19%
151,870
-786
-0.5% -$98.2K
MD icon
137
Pediatrix Medical
MD
$2.2B
$16.9M 0.19%
804,847
+90,580
+13% +$1.85M
CNDT icon
138
Conduent
CNDT
$253M
$16.9M 0.19%
3,904,934
+63,503
+2% +$319K
CHDN icon
139
Churchill Downs
CHDN
$6.17B
$16.8M 0.19%
175,322
+23,068
+15% +$2.29M
MTN icon
140
Vail Resorts
MTN
$5.7B
$16.7M 0.19%
76,697
+3,915
+5% +$958K
NPO icon
141
Enpro
NPO
$6.26B
$16.6M 0.19%
202,993
+10,173
+5% +$949K
AON icon
142
Aon
AON
$80.6B
$16.6M 0.19%
61,689
-1,844
-3% -$530K
GPK icon
143
Graphic Packaging
GPK
$3.35B
$16.6M 0.19%
809,410
+328,266
+68% +$6.93M
MCO icon
144
Moody's
MCO
$83.7B
$16.6M 0.19%
60,883
-208
-0.3% -$62.2K
P
145
Everpure Inc
P
$23B
$16.6M 0.19%
643,831
-6,246
-1% -$173K
WNS
146
DELISTED
WNS Holdings
WNS
$16.1M 0.18%
216,135
+20,794
+11% +$1.59M
RRC icon
147
Range Resources
RRC
$9.33B
$16.1M 0.18%
651,742
+8,817
+1% +$270K
TENB icon
148
Tenable Holdings
TENB
$3.47B
$16.1M 0.18%
354,605
-14,747
-4% -$760K
AMED
149
DELISTED
Amedisys
AMED
$16.1M 0.18%
153,151
+26,253
+21% +$3.35M
TTEK icon
150
Tetra Tech
TTEK
$8.77B
$15.8M 0.18%
578,415
+141,810
+32% +$3.89M

Similar funds

Segall Bryant & Hamill's Q2 2022 Portfolio in Review

As of Q2 2022, Segall Bryant & Hamill held 763 positions worth $8.88B, down 15% from $10.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Segall Bryant & Hamill's Q2 2022 filing shows 20 new, 297 increased, 294 reduced and 39 closed positions. Its largest new stake was Perrigo: 684,450 shares worth $27.7M. The largest sale was Western Alliance Bancorporation, an estimated $35M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Healthcare and Industrials.

  • Segall Bryant & Hamill's largest Q2 2022 buy was Perrigo: 684,450 shares worth $27.7M.
  • Segall Bryant & Hamill added most to Unilever in Q2 2022, an estimated $28M increase.
  • Segall Bryant & Hamill's biggest Q2 2022 reduction was Western Alliance Bancorporation, cutting an estimated $35M.
  • Segall Bryant & Hamill fully exited Anaplan, Inc. in Q2 2022, selling an estimated $22.7M.
  • Segall Bryant & Hamill's ten largest holdings make up 15% of its $8.88B portfolio in Q2 2022.
  • Segall Bryant & Hamill opened 20 new positions and closed 39 in Q2 2022.
  • Segall Bryant & Hamill's portfolio value fell 15% quarter-over-quarter to $8.88B.

Based on Segall Bryant & Hamill's 13F filing for Q2 2022, filed 15 Aug 2022.